Back to results
US 2014/0194443 A1Published application
Pyrazolyl-Based Carboxamides I
AssigneeGrüNenthal GmbH
InventorsSonja Nordhoff, Sebastian Wachten, Achim Kless, Felix Voss, Stefanie Ritter
Life of this patent
Estimating the term…
Abstract
The invention relates to pyrazolyl-based carboxamide compounds useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to these compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.
Claims17
A compound of general formula (I),
- wherein
- R1 denotes H;
- C1-4-aliphatic residue, unsubstituted or mono- or polysubstituted;
- or C3-6-cycloaliphatic residue or a 3 to 7 membered heterocycloaliphatic residue, in each case unsubstituted or mono- or polysubstituted and in each case optionally connected via a C1-4 aliphatic group, which in turn may be unsubstituted or mono- or polysubstituted;
- with the proviso that if R1 represents a 3 to 7 membered heterocycloaliphatic residue, said 3 to 7 membered heterocycloaliphatic residue is connected to the remaining part of the structure according to general formula (I) via a carbon atom of the 3 to 7 membered heterocycloaliphatic residue;
- R2 denotes H;
- F;
- Cl;
- Br;
- I;
- NO2;
- CN;
- CF3;
- CF2H;
- CFH2;
- R13;
- OH;
- O—R13;
- NH2;
- N(H)R13;
- N(R13)2;
- T represents C—R3 or N or N+—O−, U represents C—R4 or N or N+—O−, V represents C—R5 or N or N+—O—, W represents C—R6 or N or N+—O−, and X represents C—R7 or N or N+—O−,
- with the proviso that 0, 1, 2 or 3 of variables T, U, V, W and X independently of one another represent(s) either N or N+—O−, whereof 0 or 1 of variables T, U, V, W and X independently of one another represent(s) N+—O− and
- with the proviso that at least one of U, V and W does not represent N,
- wherein at least one of R4, R5 and R6 is selected from the group consisting of
- an unsubstituted or mono- or polysubstituted C3-6-cycloaliphatic residue;
- an unsubstituted or mono- or polysubstituted 3 to 7 membered heterocycloaliphatic residue;
- an unsubstituted or mono- or polysubstituted aryl;
- and an unsubstituted or mono- or polysubstituted heteroaryl,
- and the remaining substituents of R3, R4, R5, R6 and R7 are independently of one another selected from the group consisting of H;
- F;
- Cl;
- Br;
- I;
- NO2;
- CN;
- CF3;
- CF2H;
- CFH2;
- CF2Cl;
- CFCl2;
- R13;
- R14;
- C(═O)OH;
- C(═O)—R13;
- C(═O)R14;
- C(═O)—OR13;
- C(═O)—OR14;
- C(═O)—N(H)(OH);
- C(═N—OH)—H;
- C(═N—OH)—R13;
- C(═N—OH)—R14;
- C(═N—O—R13—H;
- —O—R13)—R13;
- C(═N—)—R;
- C(═N—O—R13)—R14;
- C(═O)NH2;
- C(═O)—N(H)R13;
- C(═O)—N(R13)2;
- C(═O)—N(H)R14;
- C(═O)—N(R14)2;
- C(═O)—N(R13)(R14);
- C(═O)—N(Ra)(Rb);
- OH;
- OR13;
- OCF3;
- OCF2H;
- OCFH2;
- OCF2Cl;
- OCFCl2;
- OR14;
- O—C(═O)R13;
- O—C(═O)R14;
- O—C(═O)—N(H)R13;
- O—C(═O)—N(H)R14;
- O—C(═O)—N(R13)2;
- O—C(═O)—N(R14)2;
- O—C(═O)—N(R13)(R14);
- O—C(═O)—N(Ra)(Rb);
- NH2;
- N(H)R13;
- N(R13)2;
- N(H)R14;
- N(R14)2;
- N(R13)(R14);
- N(Ra)(Rb);
- NH—C(═O)—R14;
- NH—C(═O)—R13;
- N(R13)—C(═O)—R13;
- N(R13)—C(═O)—R14;
- NH—S(═O)2—R13;
- N(R13)—S(═O)2—R13;
- NH—S(═O)2—R14;
- N(R13)—S(═O)2—R14;
- N(H)—C(═O)—OR13;
- N(H)—C(═O)—OR14;
- N(R13)—C(═O)—OR13;
- N(R13)—C(═O)—OR14;
- N(H)—C(═O)—NH2;
- N(H)—C(═O)—N(H)R13;
- N(H)—C(═O)—N(H)R14;
- N(H)—C(═O)—N(R13)2;
- N(H)—C(═O)—N(R14)2;
- N(H)—C(═O)—N(R13)(R14);
- N(H)—C(═O)—N(Ra)(Rb);
- N(R13)—C(═O)—NH2;
- N(R13)—C(═O)—N(H)R13;
- N(R13)—C(═O)—N(H)R14;
- N(R13)—C(═O)—N(R13)2;
- N(R13)—C(═O)—N(R14)2;
- N(R13)—C(═O)—N(R13)(R14);
- N(R13)—C(═O)—N(Ra)(Rb);
- SH;
- S—R13;
- SCF3;
- S—R14;
- S(═O)2OH;
- S(═O)2—R13;
- S(═O)2—R14;
- S(═O)—R13;
- S(═O)—R14;
- S(═O)2—OR13;
- S(═O)2—OR14;
- S(═O)2—N(H)(R13);
- S(═O)2—N(R13)2;
- S(═O)2—N(H)(R14);
- S(═O)2—N(R13)(R14);
- S(═O)2—N(Ra)(Rb);
- n represents 0 or 1,
- wherein, if n represents 1, then
- J represents C—R8 or N or N+—O−,
- K represents C—R9 or N or N+—O−,
- M represents C—R10 or N or N+—O−,
- Q represents C—R11 or N or N+—O−, and
- R represents C—R12 or N or N+—O−,
- with the proviso that 0, 1, 2 or 3 of variables J, K, M, Q and R independently of one another represent(s) either N or N+—O−, whereof 0 or 1 of variables J, K, M, Q and R independently represents N+—O−,
- wherein, if n represents 0, then
- J represents C—R8 or N or N—O− or O or S or NH or N(C1-4-aliphatic residue),
- K represents C—R9 or N or N+—O− or O or S or NH or N(C1-4-aliphatic residue),
- M represents C—R10 or N or N+—O− or O or S or NH or N(C1-4-aliphatic residue) and
- Q represents C—R11 or N or N+—O− or O or S or NH or N(C1-4-aliphatic residue),
- with the proviso that
- one of J, K, M and Q represents O or S or NH or N(C1-4-aliphatic residue) and the
- remaining of J, K, M and Q independently represent C—R8, respectively C—R9, respectively C—R10, respectively C—R11 or N or N+—O− and
- with the proviso that 0, 1, 2 or 3 of J, K, M and Q independently of one another represent
- either N or N+—O−, whereof 0 or 1 of variables J, K, M and Q represents N+—O−,
- wherein R8, R9, R10, R11 and R12 are independently of one another selected from the group consisting of H;
- F;
- Cl;
- Br;
- I;
- NO2;
- CN;
- CF3;
- CF2H;
- CFH2;
- CF2Cl;
- CFCl2;
- R13;
- R14;
- C(═O)OH;
- C(═O)—R13;
- C(═O)R14;
- C(═O)—OR13;
- C(═O)—OR14;
- C(═O)—N(H)(OH);
- C(═N—OH)—H;
- C(═N—OH)—R13;
- C(═N—OH)—R14;
- C(═N—O—R13)—H;
- C(═N—O—R13)—R13;
- C(═N—O—R13)—R14;
- C(═O)NH2;
- C(═O)—N(H)R13;
- C(═O)—N(R13)2;
- C(═O)—N(H)R14;
- C(═O)—N(R14)2;
- C(═O)—N(R13)(R14);
- C(═O)—N(Ra)(Rb);
- OH;
- OR13;
- OCF3;
- OCF2H;
- OCFH2;
- OCF2Cl;
- OCFCl2;
- OR14;
- O—C(═O)R13;
- O—C(═O)R14;
- O—C(═O)—N(H)R13;
- O—C(═O)—N(H)R14;
- O—C(═O)—N(R1)2;
- O—C(═O)—N(R14)2;
- O—C(═O)—N(R13)(R14);
- O—C(═O)—N(Ra)(Rb);
- NH2;
- N(H)R13;
- N(R13)2;
- N(H)R14;
- N(R14)2;
- N(R13)(R14);
- N(Ra)(Rb);
- NH—C(═O)—R14;
- NH—C(═O)—R13;
- N(R13)—C(═O)—R13;
- N(R13)—C(═O)—R14;
- NH—S(═O)2—R13;
- N(R13)—S(═O)2—R13;
- NH—S(═O)2—R14;
- N(R13)—S(═O)2—R14;
- N(H)—C(═O)—OR13;
- N(H)—C(═O)—OR14;
- N(R13)—C(═O)—OR13;
- N(R13)—C(═O)—OR14;
- N(H)—C(═O)—NH2;
- N(H)—C(═O)—N(H)R13;
- N(H)—C(═O)—N(H)R14;
- N(H)—C(═O)—N(R13)2;
- N(H)—C(═O)—N(R14)2;
- N(H)—C(═O)—N(R13)(R14);
- N(H)—C(═O)—N(Ra)(Rb);
- N(R13)—C(═O)—NH2;
- N(R13)—C(═O)—N(H)R13;
- N(R13)—C(═O)—N(H)R14;
- N(R13)—C(═O)—N(R13)2;
- N(R13)—C(═O)—N(R14)2;
- N(R13)—C(═O)—N(R13)(R14);
- N(R13)—C(═O)—N(Ra)(Rb);
- SH;
- S—R13;
- SCF3;
- S—R14;
- S(═O)2OH;
- S(═O)2—R13;
- S(═O)2—R14;
- S(═O)—R13;
- S(═O)—R14;
- S(═O)2—OR13;
- S(═O)2—OR14;
- S(═O)2—N(H)(R13);
- S(═O)2—N(R13)2;
- S(═O)2—N(H)(R14);
- S(═O)2—N(R13)(R14);
- S(═O)2—N(Ra)(Rb);
- with the proviso that at least one of R8, R9, R10, R11 and R12 does not denote H;
- each R13 independently of each other denotes
- C1-8-aliphatic residue, unsubstituted or mono- or polysubstituted;
- or
- C3-6-cycloaliphatic residue or 3 to 7 membered heterocycloaliphatic residue, in each case unsubstituted or mono- or polysubstituted;
- or
- C3-6-cycloaliphatic residue or 3 to 7 membered heterocycloaliphatic residue, in each case unsubstituted or mono- or polysubstituted, and in each case connected via a C1-4-aliphatic residue, unsubstituted or mono- or polysubstituted;
- each R14 independently of each other denotes
- aryl and heteroaryl residue, in each case independently of one another unsubstituted or mono- or polysubstituted,
- or
- aryl and heteroaryl residue, in each case independently of one another unsubstituted or mono- or polysubstituted and in each case connected via a C1-4-aliphatic group, unsubstituted or mono- or polysubstituted;
- Ra and Rb together with the N-atom connecting them form a 3 to 7 membered heterocyclic residue, unsubstituted or mono- or polysubstituted;
- optionally in the form of a single stereoisomer or a mixture of stereoisomers, in the form of the free compound and/or a physiologically acceptable salt thereof and/or a physiologically acceptable solvate thereof.
254 more elements
Dependencies are inferred from the claim text.